Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Buy
65
VTYX Quote, Financials, Valuation and Earnings
Last price:
$3.27
Seasonality move
:
59.51%
Day range:
$3.15 - $3.32
52-week range:
$0.78 - $3.39
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
0.96x
Volume:
1M
Avg. volume:
2M
1-year change:
10.47%
Market cap:
$222.7M
Revenue:
--
EPS (TTM):
-$1.75
Earnings Data
Next earnings date for VTYX
Aug 08
2025
Most recent earnings per share
-$0.39
Beat by $0.09
(May 8/2025)
Consensus Estimate
-$0.48
(May 8/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
VTYX Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 09/30/2025 | Q3 | -- | -- | -- | -$0.50 | -- |
| 08/08/2025 | Q2 | -- | -- | -- | -$0.47 | -- |
| 05/08/2025 | Q1 | -- | -- | -$0.39 | -$0.48 | $0.09 |
| 02/27/2025 | Q4 | -- | -- | -$0.41 | -$0.55 | $0.14 |
| 11/07/2024 | Q3 | -- | -- | -$0.50 | -$0.51 | $0.01 |
| 08/08/2024 | Q2 | -- | -- | -$0.45 | -$0.57 | $0.12 |
| 05/09/2024 | Q1 | -- | -- | -$0.62 | -$0.65 | $0.03 |
| 02/27/2024 | Q4 | -- | -- | -$0.79 | -$0.80 | $0.01 |
| 11/09/2023 | Q3 | -- | -- | -$0.92 | -$0.88 | -$0.04 |
| 08/10/2023 | Q2 | -- | -- | -$0.91 | -$0.70 | -$0.21 |
| 05/11/2023 | Q1 | -- | -- | -$0.68 | -$0.64 | -$0.04 |
| 03/23/2023 | Q4 | -- | -- | -$0.62 | -$0.61 | -$0.01 |
| 11/03/2022 | Q3 | -- | -- | -$0.59 | -$0.45 | -$0.14 |
| 08/15/2022 | Q2 | -- | -- | -$0.39 | -$0.47 | $0.08 |
| 05/12/2022 | Q1 | -- | -- | -$0.45 | -- | -- |
| 03/23/2022 | Q4 | -- | -- | -$0.35 | -- | -- |
| 11/18/2021 | Q3 | -- | -- | -$0.27 | -- | -- |
| 06/30/2021 | Q2 | -- | -- | -$0.74 | -- | -- |
| 03/31/2021 | Q1 | -- | -- | -$1.86 | -- | -- |
| 12/31/2020 | Q4 | -- | -- | -$0.79 | -- | -- |
| 09/30/2020 | Q3 | -- | -- | -$0.34 | -- | -- |
Ventyx Biosciences Earnings Questions
-
How Much did Ventyx Biosciences Generate in Revenue Last Quarter?
Ventyx Biosciences reported -- worth of top line sales in its most recent quarter.
-
Did Ventyx Biosciences Beat Earnings Last Quarter?
Ventyx Biosciences announced earnings per share of -$0.39 which represents a beat of analyst forecast a -$0.48 per share.
-
Is Ventyx Biosciences Profitable?
Ventyx Biosciences reported -- that represents -- per share over the last quarter.
-
What is the Analyst Consensus for Ventyx Biosciences EPS Next Year?
Ventyx Biosciences's earnings are forecast to decrease from -$1.97 per share to -$2.10 per share next year representing a decrease of -2.03%.
-
When is Ventyx Biosciences's Earnings Date?
Ventyx Biosciences's next earnings date is August 8, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
71
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
51
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
82
SBET alert for Jul 18
SharpLink Gaming [SBET] is down 2.6% over the past day.
Buy
68
MCRI alert for Jul 18
Monarch Casino & Resort [MCRI] is up 19.81% over the past day.
Sell
41
NEGG alert for Jul 18
Newegg Commerce [NEGG] is up 17.85% over the past day.
